Thomas Reiser/X
Jul 29, 2025, 15:53
Thomas Reiser Thanks ISTH Industry Roundtable Members
Thomas Reiser, Executive Director of International Society on Thrombosis and Haemostasis, shared a post on X:
“The incredible progress in diagnostics and patient care would not be possible without the support and collaboration with our pharma, biotech and medical device partners – thank you to those dedicated companies and individuals who form the ISTH Industry Roundtable.”
Find More Posts on Hemostasis Today.
-
Sep 24, 2026, 18:12Alan Nurden: How Genotype and Phenotype Can Vary in von Willebrand Disease
-
Sep 24, 2026, 16:02Leonardo Roever: Understanding Peripheral Artery Disease in the Modern Era
-
Sep 24, 2026, 15:49Sthanu Subramanian: When HbA1c Does Not Reflect True Glycemia
-
Sep 24, 2026, 15:09Caroline Voltz-Girolt: Accelerating the Development of Innovative Therapies for Rare Blood Disorders
-
Sep 24, 2026, 15:00Gambo Ramatu: Anemia as a Preventable Pregnancy Challenge
-
Sep 24, 2026, 14:56Holly John: Sickle Cell Disease Beyond Pain and Clinical Outcomes
-
Sep 24, 2026, 14:45Bruce Holland: Ex Vivo Assessment of ActiGraft Clot Formation Under Anticoagulation
-
Sep 24, 2026, 14:33Mohamed El Belghiti Alaoui: Thrombin as a Therapeutic Target in Coagulation
-
Sep 24, 2026, 14:22Integrating Thrombosis Risk Into Menopause Care – World Thrombosis Day